These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12408693)

  • 21. Pseudofolliculitis barbae treatment: Efficacy of topical eflornithine, long-pulsed Nd-YAG laser versus their combination.
    Shokeir H; Samy N; Taymour M
    J Cosmet Dermatol; 2021 Nov; 20(11):3517-3525. PubMed ID: 33629488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: a randomized, double-blinded, placebo-controlled trial.
    Xia Y; Cho S; Howard RS; Maggio KL
    J Am Acad Dermatol; 2012 Oct; 67(4):694-9. PubMed ID: 22226431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study on a single treatment response to long pulse Nd:YAG lasers and intense pulse light therapy for hair removal on skin type IV to VI--is longer wavelengths lasers preferred over shorter wavelengths lights for assisted hair removal.
    Goh CL
    J Dermatolog Treat; 2003 Dec; 14(4):243-7. PubMed ID: 14660273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudofolliculitis barbae and related disorders.
    Halder RM
    Dermatol Clin; 1988 Jul; 6(3):407-12. PubMed ID: 3048823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudofolliculitis barbae.
    Dunn JF
    Am Fam Physician; 1988 Sep; 38(3):169-74. PubMed ID: 3046269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and treatment of pseudofolliculitis barbae.
    Brown LA
    Cutis; 1983 Oct; 32(4):373-5. PubMed ID: 6354618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nd:YAG laser treatment of recalcitrant folliculitis decalvans.
    Parlette EC; Kroeger N; Ross EV
    Dermatol Surg; 2004 Aug; 30(8):1152-4. PubMed ID: 15274709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-pulsed Nd:YAG laser vs. intense pulsed light for hair removal in dark skin: a randomized controlled trial.
    Ismail SA
    Br J Dermatol; 2012 Feb; 166(2):317-21. PubMed ID: 21999492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudofolliculitis barbae. Medical consequences of interracial friction in the US Army.
    Brauner GJ; Flandermeyer KL
    Cutis; 1979 Jan; 23(1):61-6. PubMed ID: 759123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct comparison of EMLA versus lidocaine for pain control in Nd:YAG 1,064 nm laser hair removal.
    Guardiano RA; Norwood CW
    Dermatol Surg; 2005 Apr; 31(4):396-8. PubMed ID: 15871313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laser-assisted hair removal for darker skin types.
    Battle EF; Hobbs LM
    Dermatol Ther; 2004; 17(2):177-83. PubMed ID: 15113285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Best practices and evidenced-based use of the 800 nm diode laser for the treatment of pseudofolliculitis barbae in skin of color.
    Emer JJ
    J Drugs Dermatol; 2011 Dec; 10(12 Suppl):s20-2. PubMed ID: 22577689
    [No Abstract]   [Full Text] [Related]  

  • 33. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends.
    Perry PK; Cook-Bolden FE; Rahman Z; Jones E; Taylor SC
    J Am Acad Dermatol; 2002 Feb; 46(2 Suppl Understanding):S113-9. PubMed ID: 11807473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pseudofolliculitis barbae].
    Ribera M; Fernández-Chico N; Casals M
    Actas Dermosifiliogr; 2010 Nov; 101(9):749-57. PubMed ID: 21034705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser and Light Treatments for Hair Reduction in Fitzpatrick Skin Types IV-VI: A Comprehensive Review of the Literature.
    Fayne RA; Perper M; Eber AE; Aldahan AS; Nouri K
    Am J Clin Dermatol; 2018 Apr; 19(2):237-252. PubMed ID: 28791605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hair removal with the 3-msec alexandrite laser in patients with skin types IV-VI: efficacy, safety, and the role of topical corticosteroids in preventing side effects.
    Aldraibi MS; Touma DJ; Khachemoune A
    J Drugs Dermatol; 2007 Jan; 6(1):60-6. PubMed ID: 17373163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barber Knowledge and Recommendations for Pseudofolliculitis Barbae.
    Rice X; Omar D; Goodwin BP; Adotama P
    JAMA Dermatol; 2024 Jan; 160(1):111-113. PubMed ID: 38055241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudofolliculitis Barbae in the U.S. Military, a Review.
    Tshudy MT; Cho S
    Mil Med; 2021 Jan; 186(1-2):e52-e57. PubMed ID: 33128565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudofolliculitis barbae associated with an unusual hair whorl.
    Ross EV; Evans LA; Yeager JK
    Cutis; 1993 Feb; 51(2):107-8. PubMed ID: 8453890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pseudofolliculitis Barbae clinic for the black male who has to shave.
    Galaznik JG
    J Am Coll Health; 1984 Dec; 33(3):126-7. PubMed ID: 6530503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.